Cargando…

The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study

Background Spinal stenosis is a degenerative narrowing of the spinal canal with encroachment on the neural structures by surrounding bone and soft tissue. This chronic low back condition can cause restrictions in mobility, impairment of daily activities, opioid dependence, anxiety, depression, and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakewell, Brock K, Sherman, Matthew, Binsfeld, Kimberly, Ilyas, Asif M, Stache, Stephen A, Sharma, Saloni, Stolzenberg, David, Greis, Ari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731549/
https://www.ncbi.nlm.nih.gov/pubmed/36507111
http://dx.doi.org/10.7759/cureus.29196
_version_ 1784845927991738368
author Bakewell, Brock K
Sherman, Matthew
Binsfeld, Kimberly
Ilyas, Asif M
Stache, Stephen A
Sharma, Saloni
Stolzenberg, David
Greis, Ari
author_facet Bakewell, Brock K
Sherman, Matthew
Binsfeld, Kimberly
Ilyas, Asif M
Stache, Stephen A
Sharma, Saloni
Stolzenberg, David
Greis, Ari
author_sort Bakewell, Brock K
collection PubMed
description Background Spinal stenosis is a degenerative narrowing of the spinal canal with encroachment on the neural structures by surrounding bone and soft tissue. This chronic low back condition can cause restrictions in mobility, impairment of daily activities, opioid dependence, anxiety, depression, and reduced quality of life. Spinal stenosis can be treated through surgical and nonsurgical methods, but neither has proven consistently reliable. Cannabidiol (CBD) has also been observed to have anxiolytic, anti-inflammatory, antiemetic, and antipsychotic behaviors. CBD may provide greater nonsurgical treatment options for the pain associated with spinal stenosis while minimizing the need for opioids. An observational study was undertaken to assess the effects of CBD on patients suffering from chronic spinal stenosis. Methodology This observational study was investigator-initiated and designed to determine the effect of hemp-derived CBD gel caps for patients with spinal stenosis related to low back pain and leg pain relative to patient outcomes, medication utilization, and quality of life outcome measures. A total of six physician visits would be required where a set of surveys would be filled out each four weeks apart. Results The study population consisted of 48 patients. The patient population’s age ranged from 63 to 95 years and was normally distributed, with a mean age of 75 ± 7.13 years. The sex distribution was 33% male and 67% female patients. The pain was broken down between the six visits for each of the following four questions: pain right now, usual pain level during the week, best pain level during the week, and worst pain level during the week. Usual pain levels (p < 0.001) and worst pain levels (p < 0.005) demonstrated statistically significant improvement over time, while pain right now (p > 0.05) and best pain level (p > 0.05) stayed consistent throughout without statistical significance. Conclusions This open-label, prospective, observational study found that treatment with hemp-derived CBD gel caps was associated with significant improvements in pain scores and several quality-of-life measures for patients with lumbar spinal stenosis.
format Online
Article
Text
id pubmed-9731549
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97315492022-12-09 The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study Bakewell, Brock K Sherman, Matthew Binsfeld, Kimberly Ilyas, Asif M Stache, Stephen A Sharma, Saloni Stolzenberg, David Greis, Ari Cureus Pain Management Background Spinal stenosis is a degenerative narrowing of the spinal canal with encroachment on the neural structures by surrounding bone and soft tissue. This chronic low back condition can cause restrictions in mobility, impairment of daily activities, opioid dependence, anxiety, depression, and reduced quality of life. Spinal stenosis can be treated through surgical and nonsurgical methods, but neither has proven consistently reliable. Cannabidiol (CBD) has also been observed to have anxiolytic, anti-inflammatory, antiemetic, and antipsychotic behaviors. CBD may provide greater nonsurgical treatment options for the pain associated with spinal stenosis while minimizing the need for opioids. An observational study was undertaken to assess the effects of CBD on patients suffering from chronic spinal stenosis. Methodology This observational study was investigator-initiated and designed to determine the effect of hemp-derived CBD gel caps for patients with spinal stenosis related to low back pain and leg pain relative to patient outcomes, medication utilization, and quality of life outcome measures. A total of six physician visits would be required where a set of surveys would be filled out each four weeks apart. Results The study population consisted of 48 patients. The patient population’s age ranged from 63 to 95 years and was normally distributed, with a mean age of 75 ± 7.13 years. The sex distribution was 33% male and 67% female patients. The pain was broken down between the six visits for each of the following four questions: pain right now, usual pain level during the week, best pain level during the week, and worst pain level during the week. Usual pain levels (p < 0.001) and worst pain levels (p < 0.005) demonstrated statistically significant improvement over time, while pain right now (p > 0.05) and best pain level (p > 0.05) stayed consistent throughout without statistical significance. Conclusions This open-label, prospective, observational study found that treatment with hemp-derived CBD gel caps was associated with significant improvements in pain scores and several quality-of-life measures for patients with lumbar spinal stenosis. Cureus 2022-09-15 /pmc/articles/PMC9731549/ /pubmed/36507111 http://dx.doi.org/10.7759/cureus.29196 Text en Copyright © 2022, Bakewell et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pain Management
Bakewell, Brock K
Sherman, Matthew
Binsfeld, Kimberly
Ilyas, Asif M
Stache, Stephen A
Sharma, Saloni
Stolzenberg, David
Greis, Ari
The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
title The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
title_full The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
title_fullStr The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
title_full_unstemmed The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
title_short The Use of Cannabidiol in Patients With Low Back Pain Caused by Lumbar Spinal Stenosis: An Observational Study
title_sort use of cannabidiol in patients with low back pain caused by lumbar spinal stenosis: an observational study
topic Pain Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731549/
https://www.ncbi.nlm.nih.gov/pubmed/36507111
http://dx.doi.org/10.7759/cureus.29196
work_keys_str_mv AT bakewellbrockk theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT shermanmatthew theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT binsfeldkimberly theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT ilyasasifm theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT stachestephena theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT sharmasaloni theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT stolzenbergdavid theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT greisari theuseofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT bakewellbrockk useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT shermanmatthew useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT binsfeldkimberly useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT ilyasasifm useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT stachestephena useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT sharmasaloni useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT stolzenbergdavid useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy
AT greisari useofcannabidiolinpatientswithlowbackpaincausedbylumbarspinalstenosisanobservationalstudy